Drugs / ALK Alutard 5-grasses
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT04210193 Comparator | Apr 2014 → Dec 2019 | seasonal allergic rhinitis | Lars Olaf Cardell | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALK Alutard 5-grasses | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04210193 ↗ |
| Known as | Alutard 5-grasses | “The present study demonstrates that a single, preseason ILIT booster of 1000 SQ-U Alutard 5-grasses®, re-increases the allergen specific timothy-IgG4 levels, in patients...” PMID 32368217 ↗ Apr 2020 |
| Route | Other | “0.1 mL of 10 000 SQ-U/mL (1000 SQ-U) as an intralymphatic injection” NCT04210193 ↗ |